You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Suppliers and packagers for betadine


✉ Email this page to a colleague

« Back to Dashboard


betadine

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Alcon Pharms Ltd BETADINE povidone-iodine SOLUTION/DROPS;OPHTHALMIC 018634 NDA Alcon Laboratories, Inc. 0065-0411-30 1 BOTTLE in 1 CARTON (0065-0411-30) / 30 mL in 1 BOTTLE 2000-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Betadine

Last updated: August 1, 2025

Introduction
Betadine, a well-known antiseptic formulation primarily comprising povidone-iodine, is a widely used topical disinfectant in healthcare settings. Its efficacy in preventing and treating infections has cemented its position in hospitals, clinics, and households worldwide. To ensure consistent supply, pharmaceutical companies and healthcare providers rely on an extensive network of suppliers, ranging from raw material providers to finished product manufacturers. This article provides a comprehensive overview of key suppliers for Betadine, examining the global supply chain, primary manufacturers, and procurement considerations.

Overview of Betadine and Its Composition
Betadine is a trade name owned by Purdue Pharma (globally), with the active component being povidone-iodine. This compound releases iodine, which rapidly penetrates microbial cell walls, leading to disruption of protein synthesis and cell death. The formulation is available in various forms—including solutions, ointments, sprays, and swabs—tailored for different clinical uses.

While Betadine is a commercial brand, the supply chain focuses heavily on the procurement of high-quality povidone-iodine raw materials, production capabilities of finished products, and distribution channels. The reliability of these suppliers directly influences product availability, safety, and regulatory compliance.

Raw Material Suppliers for Povidone-Iodine

The foundation of Betadine’s supply chain rests on the procurement of povidone-iodine, a complex compound synthesized through the reaction of polyvinylpyrrolidone (PVP) with iodine. The demand for high-purity povidone-iodine has driven suppliers to establish robust manufacturing processes centered in Asia, Europe, and North America.

1. Polyvinylpyrrolidone (PVP) Providers
Povidone-iodine synthesis necessitates pharmaceutical-grade PVP, which is derived mainly from polyvinyl acetate through controlled polymerization processes. Leading suppliers include:

  • Fresenius Kabi (Germany): A prominent supplier of pharmaceutical polymers, including high-quality PVP used in povidone-iodine production.
  • BASF (Germany): Offers polyvinylpyrrolidone grades suitable for pharmaceutical applications with consistent quality.
  • Ashland Global Holdings (USA): Provides PVP polymers tailored for medical and pharmaceutical uses.

2. Iodine Suppliers
Iodine is critical in the formulation, with requirements for high purity and stability. Major iodine raw material suppliers include:

  • Iofina (USA): Known for iodine extraction and purification from brine sources.
  • Mitsui & Co. (Japan): A global leader in iodine production via its extensive mining operations.
  • Albemarle Corporation (USA): Offers specialty chemicals, including high-purity iodine for pharmaceutical-grade products.

3. Synthesis and Packaging Chemicals
In addition to PVP and iodine, auxiliary chemicals like dispersing agents, stabilizers, and preservatives are sourced from specialized chemical suppliers globally, ensuring optimal formulation stability.


Manufacturers of Betadine Finished Products

The finished Betadine formulations are produced by a limited number of licensed pharmaceutical manufacturers under strict regulatory oversight, primarily in developed nations but increasingly in emerging markets.

1. Purdue Pharma
Purdue Pharma predominantly owns the Betadine brand. The company manufactures and distributes Betadine products globally, adhering to stringent FDA, EMA, and other regulatory standards.

2. Mundipharma
A satellite company of Purdue Pharma, Mundipharma supplies Betadine in many regions, especially in Europe, Asia, and Latin America. They operate manufacturing facilities that meet international Good Manufacturing Practices (GMP).

3. Local and Regional Manufacturers
In response to regional demand and price competition, various generic manufacturers produce povidone-iodine-based antiseptics. Notable among them are:

  • Reckitt Benckiser (UK): Produces similar antiseptic products under different brand names.
  • Tianjin Ruipu Pharmaceutical Co., Ltd. (China): Manufactures povidone-iodine solutions and ointments for domestic and international markets.
  • Indoco Remedies (India): Manufactures povidone-iodine formulations primarily for the Indian market.

It is crucial to recognize that some regional manufacturers produce unbranded or generic povidone-iodine solutions, which are often supplied to hospitals and pharmacies without the Betadine trademark.


Distribution and Global Supply Chain Dynamics

Global supply chains for Betadine are influenced by geopolitical factors, regulatory standards, and manufacturing capacity constraints. The supply chain comprises:

  • Raw Material Suppliers: Ensuring stable iodine and PVP supply, often affected by geopolitical stability and raw material scarcity.
  • Manufacturers: Producing finished formulation units, operating under global GMP standards.
  • Distributors and Wholesalers: Facilitating timely delivery to healthcare providers across regions.
  • Regulatory Agencies: Overseeing manufacturing compliance, affecting approval and continuity of supply.

The COVID-19 pandemic highlighted vulnerabilities within this network, leading to shortages in some regions due to disrupted raw material supplies and factory shutdowns. Manufacturers have since intensified supplier diversification strategies to mitigate future risks.


Procurement Considerations for Betadine Suppliers and Buyers

Healthcare institutions and pharmaceutical companies seeking Betadine or povidone-iodine raw materials should focus on:

  • Quality Assurance: Confirm supplier compliance with pharmacopeial standards (e.g., USP, BP, EP).
  • Regulatory Approvals: Ensure products meet local regulatory requirements, such as FDA approvals or EMA certifications.
  • Supply Chain Stability: Evaluate supplier capacity for scale-up, contingency plans, and geographic diversification.
  • Pricing and Contracts: Negotiate long-term supply agreements to mitigate price fluctuations and shortages.
  • Innovation and Formulation Capabilities: Assess suppliers’ ability to develop new formulations, including alcohol-based or alcohol-free variants.

Key players are increasingly engaging in strategic partnerships with raw material producers, investing in manufacturing capacity, and adopting digital supply chain solutions for transparency.


Emerging Trends and Future Outlook

The demand for Betadine and povidone-iodine formulations continues to grow, driven by heightened infection control protocols, especially amid global health crises. Manufacturers are innovating through:

  • Sustainable sourcing of raw ingredients.
  • Development of alternative formulations with longer shelf life or improved safety profiles.
  • Expansion into emerging markets with local production facilities.
  • Regulatory harmonization to streamline global distribution.

The competitive landscape is expected to shift as new players enter markets and existing manufacturers enhance their supply chain resilience.


Key Takeaways

  • The primary raw material suppliers for Betadine are globally recognized companies providing pharmaceutical-grade povidone-iodine and iodine, notably Fresenius Kabi, Iofina, and Mitsui & Co.
  • Major finished product manufacturers include Purdue Pharma, Mundipharma, and regional generic companies, supported by stringent regulatory compliance.
  • Supply chain vulnerabilities, including geopolitical and pandemic-related disruptions, necessitate diversification and strategic sourcing.
  • Procurement professionals should prioritize quality, regulatory compliance, supply stability, and pricing when engaging suppliers.
  • Emerging trends point toward sustainable sourcing and formulation innovation to meet rising global demand.

FAQs

1. Who are the leading manufacturers of povidone-iodine raw materials for Betadine?
Leading raw material suppliers include Fresenius Kabi (Germany), Iofina (USA), and Mitsui & Co. (Japan), specializing in pharmaceutical-grade PVP and iodine.

2. Are there generic alternatives to Betadine?
Yes. Numerous regional generic manufacturers produce povidone-iodine formulations that are marketed under different brand names or as unbranded solutions, often at lower prices.

3. How does supply chain disruption impact Betadine availability?
Disruptions in raw material supply, manufacturing capacity constraints, or regulatory delays can lead to shortages, impacting infection control protocols across healthcare settings.

4. What regulatory standards govern Betadine manufacturing and supply?
Regulations such as the FDA (USA), EMA (Europe), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S) ensure quality, safety, and efficacy standards are maintained.

5. What future trends are expected in the Betadine supply ecosystem?
Increasing emphasis on sustainable sourcing, formulation innovation, regional manufacturing, and regulatory harmonization will shape the future of Betadine supply chains.


Sources
[1] Purdue Pharma official website. (2022). Betadine Product Information.
[2] GlobalData. (2022). Pharmaceutical Raw Material Market Analysis.
[3] Iofina corporate reports. (2022). Iodine Production and Supply Chain Insights.
[4] European Medicines Agency (EMA). (2022). Medicines Regulatory Requirements.
[5] M. J. Thakur et al., "Global Supply Chain Challenges in Pharmaceutical Industry," Journal of Supply Chain Management, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.